News Express Planet

Simulocity Expands Internationally, Virtualizing Top Pharmas in Switzerland, Denmark, Germany, Italy, and Japan

Simulocity Expands Internationally, Virtualizing Top Pharmas in Switzerland, Denmark, Germany, Italy, and Japan

July 14
00:00 2021

The innovations firm has recently partnered with leading pharmaceutical companies, to deliver an immersive experience for clinicians to share best-practices and attend year-round education events

ORLANDO, Fla., July13, 2021—Simulocity’s award-winning virtual (industry) platforms have experienced rapid growth in various sectors such as healthcare, education, tradeshows and events, and many more industries. Today, the company announced that ithas now expanded its technology footprint internationally as well, delivering its world-class platform to leading pharmaceutical companies such as Galderma, Ascendis Pharma, Roche, BioNTech, Bayer, Chiesi,and Shionogi. Simulocity delivered an immersive, year-round, virtual industry platform for these global pharmaceutical companies to conduct clinical best-practice sharing, employee training, clinical trials, live and on-demand events, and corporate collaboration.In addition, the firmdevelops and integrates with vital internal corporate applications utilized at those pharmaceutical companies.

The platform enables leading pharmaceuticals around the globe to conduct recurring key clinical meetings, work collaboratively and share clinical best-practices virtually,through a single “always on” virtual venue. Their employees can connect via 3D immersive spaces, clinical forums, live webinars,and integrated social media through this innovative platform. This technology is also infused with advanced features such as gamification, a learning management system, clinical media center, gamification, and artificial intelligence via an intelligent avatar that serves as a virtual concierge for clinicians to get answers to hundreds of FAQs. As more companies opt for virtualizing their operations, plus corporate events into a hybrid and/or virtual modality, Simulocity has delivered innovative, award-winning platforms that can meet the needs of every type of industry or organization.

“We are pleased to continue serving a growing list of the worlds top pharmaceuticalswith our technologies. Our Virtual Industry Platforms(VIPs) have been expanding rapidly around the globe, with over 22 pharmaceuticals in more than 12 countries already virtualized with our immersive platforms, including in Switzerland, Denmark, Germany, Italy, and Japan”, said Dr. Manny Dominguez, CEO of Simulocity.Our clients really enjoy our platform’s powerful, engagingand immersive, luxury-feel, that makes you feel “Virtually There!”.

Simulocity’s Virtual Industry Platform (VIP) is an award-winning platform, with an immersive, innovative, and luxurious experience in a modern modality that really feels like an entertainment platform but designed for business. It delivers a world-class experience from any internet-connected computer or mobile deviceand even accessible via low-bandwidth connectivity.Contact Information 1-844-SIM-TEAM

About the Company

Located in Orlando, Florida, Simulocity is a technology solutions firm comprised of top innovators with decades of proven results in delivering innovative and ground-breaking technologies around the globe. Simulocity develops customized simulation technologies for healthcare, education, training and events management. Their expertise is in integrating & innovating leading-edge technologies, including virtual platforms for business, virtual-reality, learning via gamification, business intelligence, combined with expert project management. Simulocity is the recipient of numerous awards, including Healthcare Tech Outlook’s -Top 10 Healthcare Simulation Solution Providers, CIO Applications’ –Top 10 Simulation Solution Providers, and CIO Review’s –20 Most Promising Gamification Technology Solution Providers.

Contact Detail:

Company Name: Simulocity
Contact Person: Media Relations
Email: Send Email
Phone No: 1-844-SIM-TEAM
Country: United States
Website Url:


About Author



Related Articles


No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment